KLA478

· Hunan Kelun Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KLA478, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Single-dose,First-in-human of KLA478 [Phase 1]